Liraglutide vs Semaglutide vs Dulaglutide in Veterans With Type 2 Diabetes​Liraglutide vs Semaglutide vs Dulaglutide in Veterans With Type 2 Diabetes 

This comparative effectiveness study examines risks of kidney, cardiovascular, and death outcomes among patients with type 2 diabetes initiating glucagon-like peptide-1 receptor agonists in the Veterans Health Administration. ​This comparative effectiveness study examines risks of kidney, cardiovascular, and death outcomes among patients with type 2 diabetes initiating glucagon-like peptide-1 receptor agonists in the Veterans Health Read More

GLP-1 Receptor Agonist Order Fills and Out-of-Pocket Costs by Race, Ethnicity, and Indication​GLP-1 Receptor Agonist Order Fills and Out-of-Pocket Costs by Race, Ethnicity, and Indication 

This cohort study examines how often glucagon-like peptide-1 receptor agonist orders are filled, the out-of-pocket cost per prescription, and differences by patient race and ethnicity or indication among patients with insurance. ​This cohort study examines how often glucagon-like peptide-1 receptor agonist orders are filled, the out-of-pocket cost per prescription, and differences by patient race and Read More